Clinical trial
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally…
NCT00316927 · St. Bartholomew's Hospital, Other · Completed
Key facts
| NCT number | NCT00316927 |
|---|---|
| Title | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer |
| Official title | A Randomized Phase III Trial of Dexamethasone and Aspirin (DA) Versus Dexamethasone, Diethylstilbestrol and Aspirin (DAS) in Locally Advanced or Metastatic Cancer of the Prostate - Immediate Versus Deferred Diethylstilbestrol |
| Lead sponsor | St. Bartholomew's Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | acetylsalicylic acid, dexamethasone, diethylstilbestrol |
| Enrollment | 260 |
| Start date | Dec 1, 2002 |
| Completion | Apr 1, 2007 |
| First posted | Apr 21, 2006 |
| Last update posted | Jun 26, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: